Abstract
Doing business in Colombia can be a sobering experience for multinational companies. Recently, the CEOs of a variety of global multinationals and banks were surprised to read in the morning papers that their companies ‘became unwitting accomplices in the international drug trade’, according to the Chairman of the Oversight and Investigations Subcommittee, House Banking Committee, US House of Representatives. With that opening salvo, the war on drugs entered the corporate boardroom. United States and other global companies are fast becoming combat veterans. Such are the perils of the global marketplace, especially in the business jungle in Colombia.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
